- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/52 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
Patent holdings for IPC class C07D 215/52
Total number of patents in this class: 66
10-year publication summary
|
8
|
2
|
3
|
7
|
2
|
7
|
5
|
2
|
2
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Clear Creek Bio, Inc. | 29 |
9 |
| AstraZeneca AB | 2897 |
6 |
| Ohio State Innovation Foundation | 2146 |
4 |
| Hendrix College | 16 |
4 |
| Ferring B.V. | 706 |
3 |
| F. Hoffmann-La Roche AG | 7945 |
2 |
| Bayer Pharma AG | 1052 |
2 |
| Kabushiki Kaisha Yakult Honsha | 386 |
2 |
| Kowa Company, Ltd. | 1198 |
2 |
| University of Cincinnati | 870 |
2 |
| Hoffmann-La Roche Inc. | 3447 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| Merck Patent GmbH | 5812 |
1 |
| Allergan, Inc. | 2340 |
1 |
| Bayer Schering Pharma AG | 384 |
1 |
| Board of Regents, The University of Texas System | 5821 |
1 |
| Mitsui Chemicals, Inc. | 3224 |
1 |
| The Board of Regents of the University of Oklahoma | 616 |
1 |
| City of Hope | 994 |
1 |
| Cognis IP Management GmbH | 632 |
1 |
| Other owners | 20 |